The current results link increased APN levels with MCS, suggesting that early choline supplementation could potentially provide lifelong benefits for individuals with DS and T2DM through an increase in brain APN concentrations, potentially normalizing dysregulation seen in the T2DM pathway. The gene discussed is ANPEP; the disease is Dravet syndrome.